Facebook Twitter LinkedIn YouTube Instagram

To navigate the following site navigation expect to utilize the tab key to move through items sequentially. The spacebar or enter keys can be utilized to interact with items that open sub-navigation.

The next tab will be the search box toggle. Hit enter to open the search, focus will automatically shift to the search bar. Type a letter into the search input and suggested results will appear.

Drug

CMK389

Status:

Phase 2

Condition:

Sarcoidosis ILD

Intervention Type:

Intravenous (IV) Injection

Funder Type:

Industry

Drug Details

CMK389 is an IL-18 Inhibitor.

Study Purpose

The purpose of this proof of concept study is to determine whether CMK389 displays the safety and efficacy profile to support further development in chronic pulmonary sarcoidosis.

Find a Clinical Trial